敲低Hsa_circ_0020080通过调节脂代谢对人乳腺癌细胞增殖、迁移及侵袭的促进作用*

doi:10.3969/j.issn.1671-2587.2025.01.005

临床输血与检验 ›› 2025, Vol. 27 ›› Issue (1): 34-47.DOI: 10.3969/j.issn.1671-2587.2025.01.005

敲低Hsa_circ_0020080通过调节脂代谢对人乳腺癌细胞增殖、迁移及侵袭的促进作用^*

王凌霞, 李晓, 徐诗靓, 王波, 杨欢

苏州大学附属第二医院,江苏苏州 215000

收稿日期:2024-05-23 发布日期:2025-02-25
通讯作者: 杨欢,主要从事输血及肿瘤学研究,（E-mail）zjyhcherry@126.com。
作者简介:王凌霞,主要从事肿瘤分子生物学研究,（E-mail）1820879444@qq.com。
基金资助:
*本课题受国家自然科学基金青年项目（No.81702078）、姑苏卫生人才计划人才科研项目（No.GSWS2023041）、苏州市卫生青年骨干人才“全国导师制”项目（No.Qngg2023008）、苏州市科技计划项目（No.SKY2021045、No.SKJY2021097）、苏州大学附属第二医院预研项目（No.SDFEYBS2218）资助

Knockdown of Hsa_Circ_0020080 Promotes Proliferation, Migration and Invasion of Human Breast Cancer Cells by Regulating Lipid Metabolism

WANG Lingxia, LI Xiao, XU Shiliang, WANG Bo, YANG Huan

The Second Affiliated Hospital of Soochow University,Suzhou, Jiangsu 215000

Received:2024-05-23 Published:2025-02-25

摘要/Abstract

摘要： 目的本研究旨在探讨敲低Hsa_circ_0020080通过调节脂代谢对人乳腺癌细胞增殖、迁移和侵袭行为的影响。方法定量实时荧光PCR（qRT-PCR）验证Hsa_circ_0020080敲低效率及MDM2、VEGF、FASN、HMGCR、CPT1A、SREBP1基因表达水平。Western blot检测MDM2、VEGF蛋白表达水平。体外采用克隆形成和CCK8实验检测细胞增殖功能;Transwell迁移和基质胶侵袭实验检测细胞迁移和侵袭功能。体内构建裸鼠乳房脂肪垫下移植瘤。免疫组化检测MDM2、VEGF、FASN、HMGCR、SREBP1蛋白表达。油红O染色和甘油三酯试剂盒检测甘油三酯表达量。利用脂肪酸合成酶FASN有效抑制剂（C75）进行增殖、迁移和侵袭相关的功能回补实验。结果体外敲低Hsa_circ_0020080能够增加乳腺癌细胞克隆形成、增殖、迁移及侵袭能力,促进MDM2、VEGF、FASN、HMGCR、CPT1A、SREBP1基因及MDM2、VEGF蛋白表达,增加乳腺癌细胞甘油三酯含量;体内敲低Hsa_circ_0020080促进裸鼠移植瘤的生长,增加MDM2、VEGF、FASN、HMGCR、SREBP1蛋白表达及裸鼠移植瘤组织甘油三酯水平。C75能部分逆转敲低Hsa_circ_0020080对乳腺癌细胞增殖、迁移及侵袭功能的促进作用。结论敲低Hsa_circ_0020080可以通过脂代谢促进乳腺癌细胞的增殖、侵袭及迁移功能,提示Hsa_circ_0020080在乳腺癌发展中发挥着重要的生物学作用。

关键词: Hsa_circ_0020080, 乳腺癌, 增殖, 迁移, 侵袭, 脂代谢

Abstract: Objective The purpose of this study was to explore the effect of knockdown of Hsa_circ_0020080 on the proliferation, migration and invasion of human breast cancer cells by regulating lipid metabolism. Methods Quantitative real-time fluorescence PCR (qRT PCR) was used to validate the efficiency of Hsa_circ_0020080 knockdown and the expression levels of MDM2, VEGF, FASN, HMGCR, CPT1A, SREBP1. Western blot was used to detect the expression levels of MDM2 and VEGF proteins. Cell proliferation function was examined in vitro using colony formation and CCK8 assays; Transwell migration and matrigel invasion experiments were conducted to detect cell migration and invasion functions. Transplanted tumor model of nude mice was established in vivo. Immunohistochemistry was used to detect the protein expression of MDM2, VEGF, FASN, HMGCR, and SREBP1ere detected by. Oil red O staining and triglyceride assay kit were used to detect the expression levels of triglyceride. Functional rescue experiments were conducted by the effective inhibitor of fatty acid synthase FASN (C75). Results The Knockdown of Hsa_circ_0020080 in vitro could increase the colony formation, proliferation, migration and invasion ability of breast cancer cells, promote the expression of MDM2, VEGF, FASN, HMGCR, CPT1A, SREBP1 genes and MDM2, VEGF proteins, and increase the triglyceride content of breast cancer cells; The Knockdown of Hsa_circ_0020080 in vivo promotes the growth of xenograft tumors in nude mice, increases the expression of MDM2, VEGF, FASN, HMGCR, SREBP1 proteins, and triglyceride levels in xenograft tumors of nude mice. C75 can partially rescue proliferation, migration and invasion ability of breast cancer cells with the knockdown of Hsa_circ_0020080. Conclusion Knockdown of Hsa_circ_0020080 promotes the proliferation, invasion and migration of breast cancer cells through lipid metabolism, which plays an important biological role in the development of breast cancer.

Key words: Hsa_circ_0020080, Breast cancer, Proliferation, Migration, Invasion, Lipid metabolism

中图分类号:

R737.9

王凌霞, 李晓, 徐诗靓, 王波, 杨欢. 敲低Hsa_circ_0020080通过调节脂代谢对人乳腺癌细胞增殖、迁移及侵袭的促进作用^*[J]. 临床输血与检验, 2025, 27(1): 34-47.

WANG Lingxia, LI Xiao, XU Shiliang, WANG Bo, YANG Huan. Knockdown of Hsa_Circ_0020080 Promotes Proliferation, Migration and Invasion of Human Breast Cancer Cells by Regulating Lipid Metabolism[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2025, 27(1): 34-47.

参考文献

[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] SIEGEL R L,MILLER K D,GODING SAUER A,et al.Colorectal cancer statistics,2020[J].CA Cancer J Clin,2020,70(3):145-164.
[3] HAN B F,ZHENG R S,ZENG H M,et al.Cancer incidence and mortality in China,2022[J].J Natl Cancer Cent,2024,4(1):47-53.
[4] ZHANG W X,HE Y X,ZHANG Y.CircRNA in ocular neovascular diseases:fundamental mechanism and clinical potential[J].Pharmacol Res,2023,197:106946.
[5] YI J,WANG L,HU G S,et al.CircPVT1 promotes ER-positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS[J].EMBO J,2023,42(10):e112408.
[6] YE F Z,LIANG Y R,WANG Y J,et al.Cancer-associated fibroblasts facilitate breast cancer progression through exosomal circTBPL1-mediated intercellular communication[J].Cell Death Dis,2023,14(7):471.
[7] ZHOU B X,MO Z H,LAI G E,et al.Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-𝜅B-IL-6 axis of tumor-associated macrophages[J].J Exp Clin Cancer Res,2023,42(1):48.
[8] ZHU J J,THOMPSON C B.Metabolic regulation of cell growth and proliferation[J].Nat Rev Mol Cell Biol,2019,20(7):436-450.
[9] SONG L T,LIU Z H,HU H H,et al.Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy[J].Nat Commun,2020,11(1):5842.
[10] XU S,CHEN T T,DONG L H,et al.Fatty acid synthase promotes breast cancer metastasis by mediating changes in fatty acid metabolism[J].Oncol Lett,2021,21(1):27.
[11] BRUMMER T,ZEISER R.The role of the MDM2/p53 axis in antitumor immune responses[J].Blood,2024,143(26):2701-2709.
[12] WANG W,ALBADARI N,DU Y,et al.MDM2 inhibitors for cancer therapy:the past,present,and future[J].Pharmacol Rev,2024,76(3):414-453.
[13] ADAMS C M,MITRA R,XIAO Y C,et al.Targeted MDM2 degradation reveals a new vulnerability for p53-inactivated triple-negative breast cancer[J].Cancer Discov,2023,13(5):1210-1229.
[14] KONG D G,ZHOU H B,NEELAKANTAN D,et al.VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk[J].Oncogene,2021,40(5):964-979.
[15] WU H S,XU J Y,GONG G L,et al.CircARL8B contributes to the development of breast cancer via regulating miR-653-5p/HMGA2 axis[J].Biochem Genet,2021,59(6):1648-1665.
[16] WEI W X,QIN B F,WEN W J,et al.FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth[J].Signal Transduct Target Ther,2023,8(1):187.
[17] XU S W,WU X M,WANG S C,et al.TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase[J].J Clin Invest,2024,134(5):e166149.
[18] KHOO T,CHINOY H.Anti-HMGCR immune-mediated necrotising myopathy:addressing the remaining issues[J].Autoimmun Rev,2023,22(12):103468.
[19] ZHANG G H,JIANG P S,TANG W,et al.CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity[J].Mol Cell,2023,83(23):4370-4385.e9.
[20] BIDAULT G,VIRTUE S,PETKEVICIUS K,et al.SREBP1-induced fatty acid synthesis depletes macrophages antioxidant defences to promote their alternative activation[J].Nat Metab,2021,3(9):1150-1162.
[21] CHEN F,DAI X D,ZHOU C C,et al.Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma[J].Gut,2022,71(7):1315-1325.
[22] BERRELL N,SADEGHIRAD H,BLICK T,et al.Metabolomics at the tumor microenvironment interface:decoding cellular conversations[J].Med Res Rev,2024,44(3):1121-1146.

敲低Hsa_circ_0020080通过调节脂代谢对人乳腺癌细胞增殖、迁移及侵袭的促进作用^*

Knockdown of Hsa_Circ_0020080 Promotes Proliferation, Migration and Invasion of Human Breast Cancer Cells by Regulating Lipid Metabolism

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	沈汉影, 汤宝林, 强萍. 恶性血液病患者侵袭性真菌病的研究进展[J]. 临床输血与检验, 2025, 27(2): 274-282.
[2]	刘卿, 王宗奎, 徐俊, 程露, 李长清, 杜晞, 马莉. 不同来源人血清白蛋白对血管内皮细胞生物学效应的影响研究^*[J]. 临床输血与检验, 2024, 26(5): 577-586.
[3]	陈鑫, 邵小宝, 薛昌雯, 周琳, 朱培元. 丹参酮ⅡA抑制血小板与肿瘤细胞相互作用的实验研究^*[J]. 临床输血与检验, 2024, 26(2): 187-195.
[4]	薛昌雯, 邵小宝, 陈鑫, 周琳, 朱培元. 银杏内酯B抑制血小板与肿瘤细胞相互作用的实验研究^*[J]. 临床输血与检验, 2024, 26(2): 205-212.
[5]	乔剑, 刁春红, 于洋, 张娜, 常梦远. 吴茱萸碱通过调节HMGB1/TLR4/NF-κB信号通路减轻大鼠输血相关性急性肺损伤^*[J]. 临床输血与检验, 2023, 25(5): 599-606.
[6]	罗婧菱, 杨磊. 机采血小板成分输注对肝癌细胞增殖转移的影响^*[J]. 临床输血与检验, 2023, 25(4): 456-460.
[7]	刘挺, 文燕平. miR-532-3p靶向SERPINE1调控细胞外基质受体互作通路抑制结肠腺癌细胞增殖和迁移[J]. 临床输血与检验, 2023, 25(3): 324-333.
[8]	王之丰, 孙昊, 胡电, 金志军, 刘晓军. lncRNAs ABHD11-AS1靶向miR-133a上调EGFR表达促进卵巢癌细胞增殖^*[J]. 临床输血与检验, 2022, 24(5): 574-581.
[9]	吴军营, 王凌霞, 吴茜茜, 朱志宸, 王波, 杨欢. NFKBIZ基因在乳腺癌中的生物学功能及临床诊断价值研究^*[J]. 临床输血与检验, 2022, 24(4): 482-487.
[10]	施岚, 许良飞, 聂正超, 常文娇, 马筱玲. 金葡菌杀白细胞素S组分LukS-PV抑制急性髓系白血病细胞增殖的机制研究^*[J]. 临床输血与检验, 2020, 22(6): 603-609.
[11]	李桂芳, 刘会兰, 耿良权, 皖湘, 徐修才, 孙自敏, 张世阳. 经典型BCR-ABL1阴性MPNs患者JAK2、CALR及MPL基因突变检测及临床分析[J]. 临床输血与检验, 2020, 22(5): 537-541.
[12]	赵星云, 卞茂红. MicroRNAs与红系生长发育、增殖、分化及凋亡相关性研究进展[J]. 临床输血与检验, 2020, 22(4): 445-448.
[13]	吴秀成. 血清FGF-21和E-FABP与多囊卵巢综合征患者糖脂代谢指标相关性研究[J]. 临床输血与检验, 2020, 22(3): 308-311.
[14]	刘素蕊, 杨晓亚, 高裕华, 王更银. 葡萄糖酸钙和氯化钙制备的血小板凝胶上清对脐带间充质干细胞作用的比较[J]. 临床输血与检验, 2020, 22(1): 28-31.
[15]	朱蓓, 方亮, 王营营. 非小细胞肺癌患者血清HMGB1和PD-L1检测的临床分析[J]. 临床输血与检验, 2020, 22(1): 55-57.